Systemic Treatment Plus Embolization Reduces Risk of Death in Patients With Hepatocellular Carcinoma

Compared to embolization alone, the systemic treatment combination nearly doubled progression-free survival among patients with unresectable liver cancer.

Related Keywords

California ,United States ,San Francisco ,China ,Spain ,American ,Susan Galbraith ,Durvalumab Imfinzi ,Bruno Sangro ,Astrazeneca ,Universidad De Navarra ,